Unknown

Dataset Information

0

Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum.


ABSTRACT:

Background

Colostrum is the primary source of maternal immunoglobulin A (IgA) for the newborn. IgA participates in protection and regulation mechanisms of the immune response at the neonate's mucosa. Several studies have evaluated infectious diseases and vaccine protocols effects during pregnancy on maternal milk IgA levels, with the aim to understand lactation protecting effect on newborn. However, most of their results demonstrated that there were no differences in the total IgA levels. In humans, IgA has two subclasses (IgA1 and IgA2), they have an anatomical distribution among mucosal compartments, their levels vary after antigen stimulation and are also seen to describe differential affinities in colostrum. Although there are differences between IgA subclasses in several compartments, these studies have excluded specific colostrum IgA1 and IgA2 determination.

Methods

We analyzed data from 900 women in Mexico City. With Pearson correlation, we compared the number of infectious episodes during their pregnancy that was associated with mucosal compartments (skin, respiratory and gastrointestinal tracts) and colostrum IgA subclasses.

Results

We show a correlation between increased colostrum IgA1 levels and the number of infectious episodes at respiratory tract and the skin. In contrast, infections at the gastrointestinal tract correlated with increased IgA2 amounts.

Conclusions

Infections present during pregnancy at certain mucosal site increase specific IgA subclasses levels in human colostrum. These results will help in understanding infections and immunizations effects on maternal IgA at the mammary gland, and their impact on the development and protection of the newborn.

SUBMITTER: Sanchez-Salguero E 

PROVIDER: S-EPMC6558797 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum.

Sánchez-Salguero Erick E   Mondragón-Ramírez Geovanni Kaleb GK   Alcántara-Montiel Julio C JC   Cérbulo-Vázquez Arturo A   Villegas-Domínguez Xóchitl X   Contreras-Vargas Víctor Manuel VM   Thompson-Bonilla María Del Rocío MDR   Romero-Ramírez Héctor H   Santos-Argumedo Leopoldo L  

Maternal health, neonatology and perinatology 20190611


<h4>Background</h4>Colostrum is the primary source of maternal immunoglobulin A (IgA) for the newborn. IgA participates in protection and regulation mechanisms of the immune response at the neonate's mucosa. Several studies have evaluated infectious diseases and vaccine protocols effects during pregnancy on maternal milk IgA levels, with the aim to understand lactation protecting effect on newborn. However, most of their results demonstrated that there were no differences in the total IgA levels  ...[more]

Similar Datasets

| S-EPMC2643523 | biostudies-literature
| S-EPMC9788813 | biostudies-literature
| S-EPMC8601722 | biostudies-literature
| S-EPMC7833773 | biostudies-literature
| S-EPMC8370093 | biostudies-literature
| S-EPMC3356285 | biostudies-literature
| S-EPMC2777980 | biostudies-literature
| S-EPMC3559598 | biostudies-literature
| S-EPMC11447075 | biostudies-literature
| S-EPMC3902941 | biostudies-literature